Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1987 1
1993 1
1994 1
2003 2
2006 1
2007 1
2010 2
2011 2
2012 2
2013 4
2014 3
2015 2
2017 2
2018 3
2019 3
2020 4
2021 7
2022 4
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
A predictive model for acute exacerbation of idiopathic interstitial pneumonias.
Karayama M, Aoshima Y, Suzuki T, Mori K, Yoshizawa N, Ichikawa S, Kato S, Yokomura K, Kono M, Hashimoto D, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Goshima S, Inui N, Suda T. Karayama M, et al. Among authors: aoshima y. Eur Respir J. 2023 May 5;61(5):2201634. doi: 10.1183/13993003.01634-2022. Print 2023 May. Eur Respir J. 2023. PMID: 36822633 Free PMC article.
Transient leukocytopenia following combination therapy for COVID-19.
Tsuchiya K, Fujisawa T, Mochizuka Y, Takuma S, Oishi K, Endo Y, Tanaka Y, Fukada A, Watanabe H, Katsumata M, Aoshima Y, Inoue Y, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T. Tsuchiya K, et al. Among authors: aoshima y. Respir Investig. 2022 Jan;60(1):158-161. doi: 10.1016/j.resinv.2021.09.007. Epub 2021 Oct 9. Respir Investig. 2022. PMID: 34649811 Free PMC article.
Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumonias.
Suzuki T, Karayama M, Aoshima Y, Mori K, Yoshizawa N, Ichikawa S, Kato S, Yokomura K, Kono M, Hashimoto D, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Goshima S, Inui N, Suda T. Suzuki T, et al. Among authors: aoshima y. Respirology. 2024 Feb;29(2):136-145. doi: 10.1111/resp.14621. Epub 2023 Nov 3. Respirology. 2024. PMID: 37921012
A case of severe thrombocytopenia after the first exposure to rifampicin.
Nakane C, Nishimoto K, Kishimoto E, Suzuki K, Nakagawa E, Morikawa M, Murakami Y, Aoshima Y, Matsushima S, Harada M, Uto T, Imokawa S. Nakane C, et al. Among authors: aoshima y. Respir Med Case Rep. 2023 Feb 25;42:101823. doi: 10.1016/j.rmcr.2023.101823. eCollection 2023. Respir Med Case Rep. 2023. PMID: 36915472 Free PMC article.
Riluzole-induced interstitial lung disease is a rare and potentially life-threatening adverse event successfully treated with high-dose steroid therapy: Case reports and review of the literature.
Saitoh Y, Aoshima Y, Mukai T, Abe H, Ariga H, Mori-Yoshimura M, Okamoto T, Takahashi Y. Saitoh Y, et al. Among authors: aoshima y. J Neurol Sci. 2020 Mar 15;410:116650. doi: 10.1016/j.jns.2019.116650. Epub 2019 Dec 27. J Neurol Sci. 2020. PMID: 31901592 Review.
Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study.
Koda K, Enomoto Y, Aoshima Y, Amano Y, Kato S, Hasegawa H, Matsui T, Yokomura K, Mochizuki E, Matsuura S, Koshimizu N, Morita M, Kojima S, Watanabe A, Oyama Y, Ikeda M, Kusagaya H, Uto T, Sato J, Imokawa S, Kono M, Hashimoto D, Kamiya Y, Toyoshima M, Asada K, Morita M, Mikamo M, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T. Koda K, et al. Among authors: aoshima y. Ther Adv Chronic Dis. 2022 Jun 28;13:20406223221108395. doi: 10.1177/20406223221108395. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 35782342 Free PMC article.
47 results